BPC-157 Amino Acid Sequence, Molecular Identity and Research

The BPC-157 amino acid sequence is GEPPPGKPADDAGLV (15 residues), written with terminal groups as H-GEPPPGKPADDAGLV-OH. BPC-157 is investigated in experimental research. Its published literature includes studies of cell migration, signaling proteins and gene expression in defined laboratory models.

Understanding that research starts with three separate questions: What molecule was studied? What did the experiment measure? How was the research material characterized?

This overview examines BPC-157’s molecular identity, selected cell-based findings and the documentation questions relevant to laboratory research.

What is BPC-157? Amino acid sequence and molecular identity

BPC-157 is a pentadecapeptide, meaning its sequence contains 15 amino acid residues. PubChem records the following molecular information:

Property	Reference information
Name	BPC-157
Amino acid sequence	GEPPPGKPADDAGLV
Sequence with terminal groups	H-GEPPPGKPADDAGLV-OH
Molecular formula	C62H98N16O22
Molecular weight	Approximately 1,419.5 g/mol
CAS number	137525-51-0
PubChem compound identifier	9941957

These identifiers describe the molecular entry. They do not establish the identity, composition or purity of a particular supplied lot. Source: PubChem, CID 9941957.

For material review, compare the reference identity with the supplier’s stated chemical form and lot-specific analytical documentation.

What has BPC-157 research examined?

Selected primary studies have investigated BPC-157 in rat-derived tendon fibroblasts and tissue explants. These experiments measured specific cellular responses rather than establishing a universal effect across biological systems.

Cell migration and FAK–paxillin signaling

A study published in 2011 examined rat Achilles tendon-derived fibroblasts and tendon explants. Researchers assessed cell migration, spreading, survival under oxidative stress and signaling associated with focal adhesion kinase, or FAK, and paxillin.

The authors reported increased migration and increased phosphorylation of FAK and paxillin under the tested conditions, and increased cell survival under hydrogen peroxide stress. They also reported that cell proliferation, as evaluated by MTT assay, was not directly affected by BPC-157.

That distinction matters: migration, survival and proliferation are separate experimental endpoints. A result in one should not be substituted for a result in another. The authors proposed involvement of FAK–paxillin signaling; the study does not establish a complete mechanism across all models. Source: Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS. J Appl Physiol. 2011;110(3):774–780.

Receptor expression in cultured fibroblasts

A separate study published in 2014 investigated growth hormone receptor expression in fibroblasts isolated from rat Achilles tendon.

The investigators reported changes in receptor expression at the messenger RNA level, by RT/real-time PCR, and at the protein level, by Western blot, following BPC-157 exposure. They also examined Janus kinase 2 signaling and proliferation following the addition of growth hormone to the treated cells.

These are findings from a defined cell-culture system. Receptor expression, downstream signaling and proliferation should be read as distinct observations, with attention to the experimental conditions and additional stimuli involved. Source: Chang CH, Tsai WC, Hsu YH, Pang JHS. Molecules. 2014;19(11):19066–19077.

How should laboratory findings be interpreted?

A useful literature review preserves the boundaries of each experiment.

For every BPC-157 paper, identify:

• The model: isolated cells, tissue explants or another experimental system.
• The endpoint: what the researchers directly measured.
• The comparison: the control against which the result was assessed.
• The analytical method: how the observation was recorded.
• The limitations: what the experiment did not test.

For example, a change in protein phosphorylation is a signaling observation. It does not, by itself, identify a direct molecular binding target.

Likewise, an observation in rat-derived fibroblasts cannot establish the same response in a different cell type or experimental setting. These selected papers provide research context, not an exhaustive assessment of the BPC-157 literature.

What documentation matters for BPC-157 research material?

A compound name and a purity percentage answer only part of a laboratory’s material-review questions. A practical documentation review should address the following:

Documentation item	Review question
Material identity	Does the stated sequence and chemical form match the intended research material?
Lot identification	Can the report be connected to the supplied batch?
Identity testing	What analytical evidence supports the assigned identity?
Purity result	Which method and calculation produced the reported percentage?
Assay or content	Is a quantitative content result provided, and what is its reporting basis?
Additional characterization	Are the properties required by the research documented?

This checklist is a suggested review framework, not a statement that every supplier performs the same tests. The questions are set out in more detail in How to Read a Certificate of Analysis for Research Compounds.

Why distinguish HPLC purity from content?

An HPLC area percentage expresses a peak’s share of the total included peak area. It should not automatically be interpreted as the proportion of sample mass attributable to BPC-157.

Agilent’s documentation explicitly distinguishes area-percent calculations, which do not use response factors, from calculations that account for detector response. A reported percentage therefore needs its method and reporting basis to be interpretable. Source: Agilent, Area% and Height%. This is covered at length in HPLC Purity Explained: What Area Percent Actually Measures.

Frequently asked questions

What is the amino acid sequence of BPC-157?

The sequence is GEPPPGKPADDAGLV, comprising 15 amino acid residues.

What does “pentadecapeptide” mean?

It describes a peptide containing 15 amino acid residues.

Is BPC-157’s mechanism completely established?

The studies discussed here report selected cellular responses and signaling associations. They do not establish a single, complete mechanism across experimental systems.

Does a published BPC-157 study validate a supplier’s material?

No. A research paper reports on the material and conditions used in that experiment. A separately supplied lot requires its own relevant analytical documentation.

Is a purity percentage enough to compare research materials?

No. Meaningful comparison also requires attention to identity, chemical form, analytical methods, reporting basis and the requirements of the intended experiment.

For laboratory research context only. This article does not provide guidance for human or veterinary use.

CONTINUE WITH AUREVIA

Your next research step.

Conducting laboratory research? Create a research account, or ask us about material identity and lot-specific analytical documentation.

Create a research account →Ask about documentation →

For laboratories and independent individuals conducting genuine laboratory research. First orders are verified before shipping. Not for human or veterinary use.